SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Malinoski DJ, Patel MS, Daly MC, Oley-Graybill C, Salim A; for UNOS Region 5 DMG Workgroup. The impact of meeting donor management goals on the number of organs transplanted per donor: results from the United Network for Organ Sharing region 5 prospective donor management goals study. Crit Care Med 2012;40:27732780.
  • 2
    Dikdan GS, Mora-Esteves C, Koneru B. Review of randomized clinical trials of donor management and organ preservation in deceased donors: opportunities and issues. Transplantation 2012;94:425441.
  • 3
    Schnuelle P, Gottmann U, Hoeger S, Boesebeck D, Lauchart W, Weiss C, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 2009;302:10671075.
  • 4
    Kotsch K, Ulrich F, Reutzel-Selke A, Pascher A, Faber W, Warnick P, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 2008;248:10421050.
  • 5
    D'Amico F, Vitale A, Frigo AC, Piovan D, Bertacco A, Bassi D, et al. Use of N-acetylcysteine during liver procurement: a prospective randomized controlled study. Liver Transpl 2013;18:135144.
  • 6
    Feng S. Donor intervention and organ preservation: where is the science and what are the obstacles? Am J Transplant 2010;10:11551162.
  • 7
    ACT Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT). Circulation 2011;124:12501259.
  • 8
    Birck R, Krzossok S, Markowetz F, Schnülle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003;362:598603.
  • 9
    National Science Foundation. 45 CFR part 690: federal policy for the protection of human subjects (same as 45 CFR part 46, which pertains to HHS). Subpart A: the common rule for the protection of human subjects. http://www.nsf.gov/bfa/dias/policy/docs/45cfr690.pdf. Accessed November 2012.